The company has adopted a policy of caution in the usage of natural resources and raw materials in the manufacturing process.
By the end of 2022, the company was purchasing 14.4% of its electricity made from renewable resources. The company has been able to reduce its emissions by 21% between 2021 and 2022, and 23% between 2020 and 2022.
In 2022, the company repurposed nearly 98% of its plastic waste, 89.6% of it was fit for recycling or reuse.
In a gesture to give it back to the community, the insulin-maker pharma giant has set itself a target to reduce insulin prices by 70% in the near future.
Between 2017 and 2022, the percentage of women in management positions increased from 41% to 48%. This is nearly double the US national average of 24% in 2022.
To Know more visit our ESG page.
